163 related articles for article (PubMed ID: 33748899)
1. Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma.
Hills N; Leslie M; Davis R; Crowell M; Kameyama H; Rui H; Chervoneva I; Dooley W; Tanaka T
Ann Surg Oncol; 2021 Oct; 28(11):5895-5905. PubMed ID: 33748899
[TBL] [Abstract][Full Text] [Related]
2. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
3. Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ.
Munck F; Clausen EW; Balslev E; Kroman N; Tvedskov TF; Holm-Rasmussen EV
Br J Surg; 2020 Jan; 107(1):96-102. PubMed ID: 31823362
[TBL] [Abstract][Full Text] [Related]
4. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
5. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
6. Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer.
Minami CA; Kantor O; Weiss A; Nakhlis F; King TA; Mittendorf EA
J Am Coll Surg; 2020 Oct; 231(4):434-447.e2. PubMed ID: 32771654
[TBL] [Abstract][Full Text] [Related]
7. Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer.
Prakash I; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Hyslop T; Fayanju OM
Breast Cancer Res Treat; 2021 Apr; 186(2):535-550. PubMed ID: 33206290
[TBL] [Abstract][Full Text] [Related]
8. Palliative Local Surgery for Locally Advanced Breast Cancer Depending on Hormone Receptor Status in Elderly Patients.
Pan H; Zhang K; Wang M; Ling L; Zhou W; Wang S
Clin Breast Cancer; 2019 Feb; 19(1):e247-e260. PubMed ID: 30348592
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy.
Sheaffer WW; Gray RJ; Wasif N; Stucky CC; Cronin PA; Kosiorek HE; Basu A; Pizzitola VJ; Patel B; Giurescu ME; Lorans R; McCullough AE; Ocal IT; Pockaj BA
Am J Surg; 2019 Jun; 217(6):1025-1029. PubMed ID: 30879795
[TBL] [Abstract][Full Text] [Related]
10. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
11. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
Ramzi S; Najeeb E; Coulthard J; Jenkins S
Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
Tanaka K; Masuda N; Hayashi N; Sagara Y; Hara F; Kadoya T; Matsui A; Miyazaki C; Shien T; Tokunaga E; Hayashi T; Niikura N; Maeda S; Komoike Y; Bando H; Kanbayashi C; Iwata H
Breast Cancer; 2021 Jul; 28(4):896-903. PubMed ID: 33599914
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
14. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Kondo T; Hayashi N; Ohde S; Suzuki K; Yoshida A; Yagata H; Niikura N; Iwamoto T; Kida K; Murai M; Takahashi Y; Tsunoda H; Nakamura S; Yamauchi H
J Surg Oncol; 2015 Oct; 112(5):476-80. PubMed ID: 26346047
[TBL] [Abstract][Full Text] [Related]
15. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
[TBL] [Abstract][Full Text] [Related]
16. Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base.
Miller ME; Kyrillos A; Yao K; Kantor O; Tseng J; Winchester DJ; Shulman LN
Ann Surg Oncol; 2016 Oct; 23(10):3337-46. PubMed ID: 27334212
[TBL] [Abstract][Full Text] [Related]
17. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.
Kim S; Kim J; Park HS; Kim HY; Lee K; Lee J; Lee H; Kim JY; Kim SI; Cho YU; Park BW
Yonsei Med J; 2019 Nov; 60(11):1028-1035. PubMed ID: 31637884
[TBL] [Abstract][Full Text] [Related]
18. Breast conservative surgery and local recurrence.
Rezai M; Kraemer S; Kimmig R; Kern P
Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359
[TBL] [Abstract][Full Text] [Related]
19. Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.
Rosenberger LH; Mamtani A; Fuzesi S; Stempel M; Eaton A; Morrow M; Gemignani ML
Ann Surg Oncol; 2016 Oct; 23(10):3239-46. PubMed ID: 27411549
[TBL] [Abstract][Full Text] [Related]
20. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
Rakovitch E; Pignol JP; Hanna W; Narod S; Spayne J; Nofech-Mozes S; Chartier C; Paszat L
J Clin Oncol; 2007 Dec; 25(35):5591-6. PubMed ID: 17984188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]